2:13 PM
 | 
Jan 03, 2018
 |  BC Extra  |  Politics & Policy

FDA outlines plans for generic drug competition

FDA said on Wednesday that it plans to take steps this quarter to make it difficult for branded drug companies to adopt tactics that attempt to delay generics from coming to market. The agency said the measures will address "potential abuses of the citizen petition process, companies that restrict...

Read the full 224 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >